[Corrigendum] Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer

Xi,Hong‑Qing; Cui,Jian‑Xin; Shen,Wei‑Song; Wu,Xiao‑Song; Bian,Shi‑Bo; Li,Ji‑Yang; Song,Zhou; Wei,Bo; Chen,Lin

doi:10.3892/or.2019.7120

July-2019 Volume 42 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2019 Volume 42 Issue 1

Full Size Image

Correction Open Access

[Corrigendum] Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer

Authors:
- Hong‑Qing Xi
- Jian‑Xin Cui
- Wei‑Song Shen
- Xiao‑Song Wu
- Shi‑Bo Bian
- Ji‑Yang Li
- Zhou Song
- Bo Wei
- Lin Chen
View Affiliations / Copyright

Affiliations: Department of General Surgery, Chinese People's Liberation Army General Hospital, Beijing 100853, P.R. China

Copyright: © Xi et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
Pages: 462-462
|
Published online on: April 16, 2019

https://doi.org/10.3892/or.2019.7120
Expand metrics +

Article

Oncol Rep 32: [Related article:] 181-188, 2014; DOI: 10.3892/or.2014.3207

An interested reader drew to the attention of the Journal that the western blot featured in Fig. 3B of the above paper also appeared as Fig. 3D in the following publication, featuring many of the same authors: Xi HQ, Cai AZ, Wu XS et al: Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer. Br J Cancer 110: 2011–2020, 2014. After having consulted the authors about this matter, they conceded that there was a data sharing violation here, and that the image should not have been reproduced in the above article without having received the prior permission of the British Journal of Cancer.

Figure 3.

Suppression of Lgr5 expression by siRNA in AGS gastric cancer cells. AGS cells were seeded into 6-well plates and transfected with siRNAs targeting Lgr5 (siRNA-Lgr5-409, siRNA-Lgr5-1555 and siRNA-Lgr5-2664) or scrambled siRNA (negative control). Untransfected cells served as a blank control. Lgr5 mRNA and protein expression were significantly inhibited in siRNA-transfected cells. The Lgr5-homo-2664 siRNA exerted the greatest inhibitory effects. Experiments were performed in biological triplicate with similar results. Lgr5 mRNA levels are presented as mean ± standard deviation (SD) using GAPDH as an internal control. Lgr5, leucine-rich repeat-containing G protein-coupled receptor 5. Panel (B) was reproduced with permission from Br J Cancer [Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer. Br J Cancer 110: 2011–2020, 2014].

This permission has now been sought after and obtained, and Fig. 3 is reproduced opposite, now including the appropriate credit for the original source of Fig. 3B. The authors apologize to the Editors of the British Journal of Cancer and Oncology Reports, and to the readership for any inconvenience caused.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

[Corrigendum] Increased expression of Lgr5 is associated with chemotherapy resistance in human gastric cancer

This article is mentioned in:

Article

Figure 3.

Related Articles